This inventor holds 1 USPTO granted patent. Top assignee: National Cancer Center. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Teak-Chin Cheong: Innovator in Cancer Therapeutics
Introduction: Teak-Chin Cheong is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research, particularly in the development of therapeutic agents. His innovative approach focuses on the molecular interactions that play a crucial role in cancer progression.
Latest Patents: Teak-Chin Cheong holds a patent titled "Method for screening cancer therapeutic agent using galectin-3, GSK-3β, and fascin-1." This patent discloses a method for screening a novel cancer therapeutic agent that exhibits down-regulation of galectin-3 and fascin-1 or interferes with the interaction between galectin-3 and GSK-3β. He has 1 patent to his name, showcasing his commitment to advancing cancer treatment methodologies.
Career Highlights: Teak-Chin Cheong is affiliated with the National Cancer Center, where he conducts research aimed at improving cancer therapies. His work is characterized by a strong focus on the molecular mechanisms underlying cancer, which has the potential to lead to more effective treatment options for patients.
Collaborations: Some of his notable coworkers include Kyung-Hee Chun and Seok-Jun Kim. Their collaborative efforts contribute to the advancement of cancer research and the development of innovative therapeutic strategies.
Conclusion: Teak-Chin Cheong's work in cancer therapeutics exemplifies the impact of innovative research on medical science. His contributions are paving the way for new approaches to cancer treatment, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile